Article
Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population.
Virology journal - 9 Dec 2013
Mansoor Atika, Ali Lubna, Sabah Noor-ul, Hashmi Asraf Hussain, Khan Mohammad Haroon, Kazmi Syed Ali Raza, Ahmad Nafees, Siddiqi Saima, Khan Khalid Mehmood
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma and infects about 3% world population. Response to interferon therapy depends upon the genotype of the virus and factors associated with the host. Despite a good response to interferon therapy, a considerable number of genotype 3a infected patients remains unalleviated. RESULTS: In total forty-nine patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
